Define Ventures

We're thrilled to welcome Bruce Broussard, former CEO and President of Humana, as Venture Partner at Define Ventures. After collaborating for nearly a decade, we're excited to deepen our partnership and drive transformative change in healthcare together. Bruce's exceptional track record in scaling healthcare organizations - from startups to Fortune 50 companies - will be instrumental in guiding our founders building the next generation of category-defining healthcare companies. In his own words, "What excites me the most about this role is the opportunity to work with brilliant, innovative entrepreneurs at the earliest stages of their journey."

Healthcare’s relationship with AI is complex, and the opportunities are undeniable. That’s why we conducted comprehensive research with over 60 of our closest partners, unpacking how the C-suite at the largest payers and providers are navigating the unprecedented speed of AI innovation. If you're a founder building in this space, this report provides critical insights to inform your market readiness and commercial strategies, understanding where and how these large organizations are looking to partner with companies. If you're a health plan or health system executive, this report similarly provides valuable takeaways in understanding how your peers are building and investing in their AI strategies. The report link is in the comments.

Our founder & managing partner Lynne Chou O'Keefe recently sat down with Bloomberg's Jonathan Palmer for an in-depth discussion on our unique approach to healthcare investing, including the importance of providing founders with both healthcare and tech expertise. The link to the episode is in the comments; the two also cover the major trends shaping healthcare, including AI, consumerization, and the evolution of the value chain.

The All Raise #VCSummit brings together those who are committed to inspire, educate, and connect around what's possible for women and nonbinary VCs. Our founder & managing partner Lynne Chou O'Keefe is looking forward to leading a breakout session at #VCSummit24, sharing her real experiences and lessons learned on how to play to win.

What are the three things our founder & managing partner Lynne Chou O'Keefe thinks through in her first meeting with a founder? She evaluates founders and their disruptive ideas and approaches through the lens of our core values: Defining Healthcare - What is your specific insight or market edge to redefine healthcare? And does it align with your background and expertise? Defining Partnership - How can the Define team uniquely support you and provide you with unfair advantages to reach your mission? Defining Leadership - What are your own core values and do they align with ours? Are you focused on building your company and surrounding team with the highest ethical standard? #HLTH2024 #HLTHUSA

Why is only 3% of our healthcare dollars going towards public and preventive health services? It all comes down to how incentives are aligned, explained our strategic partner Chief Clinical Innovation Officer Dr. Richard Milani of Sutter Health. For example, once you have a heart attack you'll be able to get critical services around diet, exercise, and stress management covered. But if you're at risk for having a heart attack in the next six months, you won't be able to get those same services covered. #HLTH2024

"We could just scale the same foolishness or actually do something differently." Our strategic partner Sara Vaezy at Providence emphasized that while AI itself isn't necessarily new, the technology now at our fingertips is drastically different. For example, a few years ago we weren't able to parse very complicated and unstructured data. As Sara emphasized, this AI unlock allows organizations like Providence to build patient-centered and clinician-centered solutions. #HLTH2024

Are GLP-1s a “magical” medication? Not quite, according to hims & hers SVP of weight loss Craig Primack MD, FACP, FAAP. MFOMA, Dipl. ABOM. Instead, they’re a strong lever to a healthier lifestyle. That’s why hims & hers is especially focused on building trust and accountability with their patients. That way they can help build the necessary muscle around daily movement, a well-rounded diet, and more. #HLTH2024

What if employers could make healthcare purchasing decisions just like consumers do? Thoughtfully weighing the tradeoffs rather than the all-too-often “take it or leave it” approach. Centivo founder & CEO Ashok Subramanian shared a customer example to emphasize this point. Rather than forcing an arbitrary decision around how to cover their employees, they were able to have a thoughtful partnership with a grocery chain in the Northeast, aligning on the best way for their employees to access care.

Noom is rolling out a new solution that aim to make it easier for employers and members to manage GLP-1s, and it's teaming up with our partner company Waltz Health to power one of the offerings. Waltz will bring direct and cost-effective access to GLP-1 drugs by going around traditional middlemen, all with the goal of encouraging more employers and payers deciding to cover GLP-1s. #HLTH2024